Welcome to the home page of the Office of Technology Commercialization at Georgetown University. The duties of the Office of Technology Commercialization (OTC) include management of Georgetown invention disclosures, patenting and licensing activities, oversight of material transfer agreements and confidentiality agreements, and engagement of Georgetown University in the founding and growth of local businesses.


SAVE THE DATE for our next "Invention to Innovation" seminars ("I2Is") on May 18th and June 4th

Read our Recent Quarterly Newsletter, the OTC Review (inaugural issue available here)

Georgetown University and Amarantus Bioscience Holdings Sign Exclusive Option Agreement -- Jan. 15, 2015

NPR Article on Dr. Richard Schlegel's work on cervical cancer treatment -- Jan. 7, 2015

NPR Article on Dr. Bob Clarke's work on human cancer cell lines - Dec. 9, 2014

FUNDING OPPORTUNITY: Bill & Melinda Gates Foundation Global Health & Development Awards

Georgetown Biology professor named D.C. Professor of the Year (Georgetown News)

Researcher Debunks Alzheimer's Prevailing Development Theory (Georgetown Research News)


Investigators, check out Industry Collaboration Opportunities HERE

Our Suggestion Box is now live! We invite the Georgetown community to share feedback on any aspect of OTC's activities.

New Technologies for Licensing: "Method for Enhancing the Legibility of Degraded Documents", "Blood-Based Biomarkers", and "Markers for Abnormal Cell"

Georgetown Inventors Howard Federoff and Massimo Fiandaca Featured for New Technology Predicting Alzheimer's and Dementia

Congratulations to Dr. Ken Kellar (Recipent of the 2015 Langley Award from the Society for Research in Nicotine and Tobacco (SRNT)

Other Stories Here

What is Technology Transfer?

Watch the Association of University Technology Managers (AUTM)'s site and video featuring the ins and outs of Technology Transfer and learn more about what is involved in its process.